Boli Li

Title: Boli Li - Innovator in Pharmaceutical Composition

Introduction

Boli Li is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for neurological treatments. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Boli Li holds a patent for a composition containing lamotrigine, along with its preparation method and use. The patent describes a dry pharmaceutical composition that includes a therapeutically effective amount of one or more lamotrigine hydrate crystals and one or more pharmaceutically acceptable excipients. The excipients include a thickener, and the composition is designed to be a dry suspending agent. This formulation can be prepared into a stable suspension for administration, remaining effective for at least 1-3 months. The patent also outlines methods for preparing the dry pharmaceutical composition and its application in treating neurological diseases.

Career Highlights

Boli Li is associated with Shanghai Aucta Pharmaceuticals Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His career is marked by a commitment to advancing medical treatments through research and development.

Collaborations

Boli Li collaborates with talented professionals in his field, including Xun Zheng and Shaoqiong Lyu. These partnerships enhance the research and development efforts at Shanghai Aucta Pharmaceuticals Co., Ltd.

Conclusion

Boli Li's contributions to pharmaceutical innovation, particularly through his patent on lamotrigine compositions, highlight his role as a key figure in the industry. His work not only advances medical science but also offers hope for effective treatments for neurological diseases.